Mohamed Farouk Chughlay

A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug–Induced Liver Injury

Muhammed Shiraz Moosa, Gary Maartens, Hannah Gunter et al. · Clinical Infectious Diseases · 2020 · 54 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection

Mohamed Farouk Chughlay, Emilie Rossignol, Cristina Donini et al. · British Journal of Clinical Pharmacology · 2020 · 41 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Liver Enzyme Elevations in Plasmodium falciparum Volunteer Infection Studies: Findings and Recommendations

Mohamed Farouk Chughlay, Samantha Akakpo, Anand Odedra et al. · American Journal of Tropical Medicine and Hygiene · 2020 · 33 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +16

Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection Study

Mohamed Farouk Chughlay, Myriam El Gaaloul, Cristina Donini et al. · American Journal of Tropical Medicine and Hygiene · 2021 · 32 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial

Nomathemba Chandiwana, Chelsea Kruger, Hilary Johnstone et al. · EBioMedicine · 2022 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15